세계의 바이오의약품 제3자 물류 시장 보고서(2025년)
Biopharmaceutical Third-Party Logistics Global Market Report 2025
상품코드 : 1824341
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오의약품 제3자 물류 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 7.8%를 나타내 2,031억 8,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 개인화된 의료의 성장, 생물학적 제제 및 바이오시밀러의 확대, 공급망의 디지털화, 규제 준수의 복잡화, COVID-19의 영향으로 인한 것으로 예측됩니다. 예측 기간의 주요 동향으로는 온디맨드 물류 솔루션, 물류 지속성, 마지막 마일 배송 솔루션, 의약품 직렬화 및 추적성, 자율적 물류 등이 있습니다.

향후 5년간의 성장률 7.8%라고 하는 예측은 전회의 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 독일과 네덜란드에서 개발된 온도 관리형 운송 솔루션 및 추적 시스템의 가격을 상승시켜 콜드체인의 무결성을 저하시키고 물류 비용을 증가시켜 미국 의약품 유통에 지장을 줄 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

물류 아웃소싱 동향 증가는 바이오의약품 제3자 물류 시장 성장을 이끌 것으로 예측됩니다. 물류 아웃소싱은 기업의 물류 활동의 전부 또는 일부가 제3자에게 관리되도록 하는 것을 의미합니다. 바이오의약품 분야에서는 극저온 공급망 관리를 물류 파트너에게 아웃소싱하는 것이 이루어지고 있습니다. 예를 들어, 2024년 2월, 미국 교통부(DOT) 산하 기관인 교통통계국(Bureau of Transportation Statistics)은 2023년 12월 유상 화물 운송량이 2022년 12월 대비 1.8% 증가했다고 보고했으며, 화물 운송 서비스 지수(Freight Transportation Services Index)는 2022년 12월 136.6에서 2023년 12월 139.1로 상승했습니다. 이와 같이 물류 아웃소싱 동향 증가는 바이오의약품 제3자 물류 시장 성장을 가속할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Biopharmaceutical third-party logistics involves external partners or services that facilitate the provision of logistics services to pharmaceutical companies. These companies outsource their transportation needs to third-party providers as a cost-saving measure, and the lack of in-house capabilities significantly contributes to the growing trend of transportation outsourcing.

The primary categories of supply chains in biopharmaceutical third-party logistics are cold chain and non-cold chain. The cold chain specifically pertains to a supply chain that ensures temperature control throughout the transportation of products sensitive to temperature variations. Various services, including transportation, warehousing and storage, among others, are utilized by pharmaceutical and biopharmaceutical companies, medical device companies, hospitals and clinics, and other relevant entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biopharmaceutical third-party logistics market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical third-party logistics market statistics, including biopharmaceutical third-party logistics industry global market size, regional shares, competitors with a biopharmaceutical third-party logistics market share, detailed biopharmaceutical third-party logistics market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical third-party logistics industry. This biopharmaceutical third-party logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biopharmaceutical third-party logistics market size has grown strongly in recent years. It will grow from $141.59 billion in 2024 to $150.5 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to globalization of pharma supply chains, stringent regulatory requirements, rise in biopharmaceuticals, focus on cold chain logistics.

The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to $203.18 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to personalized medicine growth, biologics and biosimilars expansion, supply chain digitalization, regulatory compliance complexity, COVID-19 impact. Major trends in the forecast period include on-demand logistics solutions, sustainability in logistics, last-mile delivery solutions, pharma serialization and traceability, autonomous logistics.

The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug distribution by inflating prices of temperature-controlled shipping solutions and track-and-trace systems developed in Germany and the Netherlands, resulting in compromised cold chain integrity and higher logistics costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing trend of outsourcing logistics is projected to drive the growth of the biopharmaceutical third-party logistics market. Outsourcing logistics entails engaging a third party to manage all or part of a company's logistical activities. In the biopharmaceutical sector, this practice is utilized for outsourcing cryogenic supply chain management to logistics partners. For instance, in February 2024, the Bureau of Transportation Statistics, a U.S. agency under the Department of Transportation (DOT), reported a 1.8% increase in for-hire freight shipments in December 2023 compared to December 2022, while the Freight Transportation Services Index rose from 136.6 in December 2022 to 139.1 in December 2023. Thus, the increasing trend of outsourcing logistics is expected to propel the growth of the biopharmaceutical third-party logistics market.

The introduction of innovative biopharmaceutical products is anticipated to drive the growth of the biopharmaceutical third-party logistics market. Innovative biopharmaceutical products are advanced and novel therapeutic substances derived from biological sources, such as monoclonal antibodies or gene therapies. The biopharmaceutical third-party logistics market plays a vital role in the efficient launch of these products by providing streamlined supply chain solutions, ensuring timely and secure distribution, and supporting the complex logistics involved in bringing these innovative therapies to market. For instance, in January 2024, the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a U.S. branch of the Food and Drug Administration (FDA), indicated that the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Therefore, the launch of innovative biopharmaceutical products is expected to propel the growth of the biopharmaceutical third-party logistics market.

Technological advancements stand out as a prominent trend gaining momentum in the biopharmaceutical third-party logistics market. Major companies within this market are strategically launching innovative products to fortify their market position and gain a competitive edge. For example, in November 2022, Celcius Logistics Solutions Pvt Ltd., an India-based logistics services provider, introduced Hyper-Local temperature-controlled delivery services designed for food and pharmaceutical orders. The company's last-mile solution, catering to smaller quantities, is available in nine cities across the country. The hyperlocal approach ensures optimal material quality during transportation by continuously monitoring temperatures in real-time at each stage of the delivery process.

Major companies in the biopharmaceutical third-party logistics market are concentrating on innovative solutions, such as expanding their operations in life sciences and healthcare logistics, to enhance their logistics capabilities for pharmaceutical and healthcare products, ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics refers to the strategic growth of logistics companies to improve their capabilities in transporting and managing medical products, which is essential for ensuring timely delivery and maintaining the integrity of temperature-sensitive items crucial for patient care. For example, in August 2022, DHL Supply Chain, a Germany-based contract logistics specialist of Deutsche Post DHL Group, announced the expansion of its Life Sciences and Healthcare Campus in Florstadt, Germany. This expansion includes the construction of a new logistics center that will add 32,000 square meters of space dedicated to the storage and distribution of pharmaceutical and medical products. The facility will feature various temperature-controlled zones and have the capacity for 10,000 pallet locations, enabling it to handle a wide range of pharmaceutical products. This initiative aims to enhance DHL's capabilities in pharmaceutical logistics and support the increasing demands of the healthcare sector, ensuring efficient and compliant handling of sensitive medical supplies.

In March 2022, STG Logistics Inc., a US-based provider of optimized logistics and transportation services, successfully acquired the intermodal division of XPO Logistics Inc. for $710 million. This strategic move enhances STG Logistics' position in the containerized logistics industry, paving the way for further achievements. XPO Logistics Inc. is a US-based provider of asset-based less-than-truckload (LTL) freight transportation and third-party logistics, including biopharma logistics.

Major companies operating in the biopharmaceutical third-party logistics market include McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, Catalent Inc., Almac Group, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics, PCI Pharma Services

North America was the largest region in the biopharmaceutical third party logistics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biopharmaceutical third-party logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biopharmaceutical third-party logistics market consists of revenues earned by entities by providing biopharmaceutical third-party logistics such as domestic transportation management, international transportation management, and value-added warehousing and distribution. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Third-Party Logistics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical third-party logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biopharmaceutical third-party logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopharmaceutical third-party logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biopharmaceutical Third-Party Logistics Market Characteristics

3. Biopharmaceutical Third-Party Logistics Market Trends And Strategies

4. Biopharmaceutical Third-Party Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biopharmaceutical Third-Party Logistics Growth Analysis And Strategic Analysis Framework

6. Biopharmaceutical Third-Party Logistics Market Segmentation

7. Biopharmaceutical Third-Party Logistics Market Regional And Country Analysis

8. Asia-Pacific Biopharmaceutical Third-Party Logistics Market

9. China Biopharmaceutical Third-Party Logistics Market

10. India Biopharmaceutical Third-Party Logistics Market

11. Japan Biopharmaceutical Third-Party Logistics Market

12. Australia Biopharmaceutical Third-Party Logistics Market

13. Indonesia Biopharmaceutical Third-Party Logistics Market

14. South Korea Biopharmaceutical Third-Party Logistics Market

15. Western Europe Biopharmaceutical Third-Party Logistics Market

16. UK Biopharmaceutical Third-Party Logistics Market

17. Germany Biopharmaceutical Third-Party Logistics Market

18. France Biopharmaceutical Third-Party Logistics Market

19. Italy Biopharmaceutical Third-Party Logistics Market

20. Spain Biopharmaceutical Third-Party Logistics Market

21. Eastern Europe Biopharmaceutical Third-Party Logistics Market

22. Russia Biopharmaceutical Third-Party Logistics Market

23. North America Biopharmaceutical Third-Party Logistics Market

24. USA Biopharmaceutical Third-Party Logistics Market

25. Canada Biopharmaceutical Third-Party Logistics Market

26. South America Biopharmaceutical Third-Party Logistics Market

27. Brazil Biopharmaceutical Third-Party Logistics Market

28. Middle East Biopharmaceutical Third-Party Logistics Market

29. Africa Biopharmaceutical Third-Party Logistics Market

30. Biopharmaceutical Third-Party Logistics Market Competitive Landscape And Company Profiles

31. Biopharmaceutical Third-Party Logistics Market Other Major And Innovative Companies

32. Global Biopharmaceutical Third-Party Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical Third-Party Logistics Market

34. Recent Developments In The Biopharmaceutical Third-Party Logistics Market

35. Biopharmaceutical Third-Party Logistics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기